Orientbio Inc. (002630)
Market Closed
15 Oct, 06:30 AM
KRX SM KRX SM Primary ₩
1,510. 00
-85
-5.3292%
₩
80.51B Market Cap
- P/E Ratio
- Div Yield
42,685 Volume
- Eps
₩ 1,595
Previous Close Want to track 002630 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Orientbio Inc. (002630) Statistics
Valuation metrics
Market Cap 80.51B
Enterprise value 38.8B
Trailing P/E (ttm) 21.01
Forward P/E -
PEG ratio 0.08
Price/Sales (ttm) 1.69
Price/Book (mrq) 0.67
Enterprise Value/Revenue 1.35
Enterprise Value/EBITDA 7.19
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 44.02K
Average volume (90 days) 283.61K
Price summary
52-Week low 1,490
52-Week high 3,264
Beta -
50-Day moving average 1,166.42
200-Day moving average 834.15
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 0:1
Last split Date 22 Sep 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.08%
Operating margin 0.09%
Operational effectiveness
Return on assets 0.03%
Return on equity 0.03%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 966.94
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 77.99
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1,284.47
Total debt (mrq) -
Total Debt/Equity (mrq) 0.02
Current ratio (mrq) 14.09%
Book value per share (mrq) 2,437.8
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
